{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:25:30Z","timestamp":1777973130671,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Natural Science Foundation of China to the Innovation Research Group","award":["81621092"],"award-info":[{"award-number":["81621092"]}]},{"name":"Outstanding Young Scholar","award":["81622009"],"award-info":[{"award-number":["81622009"]}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1053\/j.ajkd.2018.01.029","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T08:18:18Z","timestamp":1520065098000},"page":"904-908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Clinical and Immunologic Features of Patients With Combined Anti-GBM Disease and Castleman Disease"],"prefix":"10.1053","volume":"71","author":[{"given":"Qiu-hua","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui-yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-zhong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.ajkd.2018.01.029_bib1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.126.6.989","article-title":"The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis","volume":"126","author":"Lerner","year":"1967","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1053\/j.ajkd.2018.01.029_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrneph.2011.89","article-title":"Advances in human anti-glomerular basement membrane disease","volume":"7","author":"Cui","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"26","key":"10.1053\/j.ajkd.2018.01.029_bib3","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1016\/S0021-9258(18)37714-7","article-title":"Identification of the Goodpasture antigen as the alpha 3(IV)\u00a0chain of collagen IV","volume":"263","author":"Saus","year":"1988","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1053\/j.ajkd.2018.01.029_bib4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1172\/JCI115625","article-title":"Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen","volume":"89","author":"Turner","year":"1992","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1053\/j.ajkd.2018.01.029_bib5","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1074\/jbc.275.8.6030","article-title":"The Goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain","volume":"275","author":"Borza","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"16","key":"10.1053\/j.ajkd.2018.01.029_bib6","doi-asserted-by":"crossref","first-page":"11267","DOI":"10.1074\/jbc.274.16.11267","article-title":"The Goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain","volume":"274","author":"Netzer","year":"1999","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1053\/j.ajkd.2018.01.029_bib7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymphnode hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"issue":"3","key":"10.1053\/j.ajkd.2018.01.029_bib8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","article-title":"Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations","volume":"29","author":"Keller","year":"1972","journal-title":"Cancer"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2018.01.029_bib9","doi-asserted-by":"crossref","first-page":"i119","DOI":"10.1093\/ndt\/gfr245","article-title":"Renal involvement in a large cohort of Chinese patients with Castleman disease","volume":"27","author":"Xu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2018.01.029_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ndt\/gfq427","article-title":"Renal involvement in Castleman disease","volume":"26","author":"El","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2018.01.029_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MAJ.0b013e318184ce4a","article-title":"Antiglomerular basement membrane disease associated with Castleman disease","volume":"337","author":"Lv","year":"2009","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1053\/j.ajkd.2018.01.029_bib12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/ndt\/13.6.1556","article-title":"Antimyeloperoxidase-antibody-positive rapidly progressive glomerulonephritis associated with Castleman's disease","volume":"13","author":"Furuichi","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"9408","key":"10.1053\/j.ajkd.2018.01.029_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(04)15539-6","article-title":"Castleman's tumours and production of autoantibody in paraneoplastic pemphigus","volume":"363","author":"Wang","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ajkd.2018.01.029_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/BOR.0b013e32834db525","article-title":"Castleman disease and associated autoimmune disease","volume":"24","author":"Muskardin","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.01.029_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1440-1827.2000.01052.x","article-title":"Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases","volume":"50","author":"Kojima","year":"2000","journal-title":"Pathol Int"},{"issue":"3","key":"10.1053\/j.ajkd.2018.01.029_bib16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/bjh.14152","article-title":"Autoimmune thrombotic thrombocytopenic purpura associated with HHV8-related multicentric Castleman disease","volume":"178","author":"London","year":"2017","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.01.029_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/ped.12710","article-title":"Anemia and autoimmunity markers in an adolescent with Castleman disease","volume":"57","author":"Fretzayas","year":"2015","journal-title":"Pediatr Int"},{"issue":"7","key":"10.1053\/j.ajkd.2018.01.029_bib18","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/ndt\/16.7.1475","article-title":"Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations","volume":"16","author":"Curioni","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2018.01.029_bib19","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1111\/j.1756-185X.2010.01476.x","article-title":"Pararenal retroperitoneal Castleman's disease mimicking systemic lupus erythematosus","volume":"13","author":"Kim","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2018.01.029_bib20","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood.V74.4.1360.1360","article-title":"Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease","volume":"74","author":"Yoshizaki","year":"1989","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.ajkd.2018.01.029_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ki.2009.348","article-title":"Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity","volume":"76","author":"Zhao","year":"2009","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2018.01.029_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2215\/CJN.05140512","article-title":"Association of epitope spreading of antiglomerular basement membrane antibodies and kidney injury","volume":"8","author":"Chen","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.01.029_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.humimm.2009.04.004","article-title":"The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity","volume":"70","author":"Zhao","year":"2009","journal-title":"Hum Immunol"},{"issue":"7","key":"10.1053\/j.ajkd.2018.01.029_bib24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7326\/0003-4819-124-7-199604010-00005","article-title":"Anti-alpha1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome","volume":"124","author":"Kalluri","year":"1996","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618301033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618301033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:12:44Z","timestamp":1759461164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638618301033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0272638618301033"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.01.029","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical and Immunologic Features of Patients With Combined Anti-GBM Disease and Castleman Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}